Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2992800 | 0.96 | CES2 (0.53) | CES2KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL2999996 | 0.96 | CES2 (0.53) | CES2KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL15188717 | 0.96 | CES2 (0.53) | CES2KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL29770831 | 0.96 | CES2 (0.53) | CES2KMT2AMEN1FAAHMAPK1 | |
| Trimethylammonium SCHEMBL466595 | 0.91 | CES2 (0.48) | CES2KMT2AMEN1FAAHMAPK1 | |
| Trimethylammonium SCHEMBL467213 | 0.91 | CES2 (0.48) | CES2KMT2AMEN1FAAHMAPK1 | |
| Trimethylammonium SCHEMBL466946 | 0.91 | CES2 (0.48) | CES2KMT2AMEN1FAAHMAPK1 | |
| Dimethylamine SCHEMBL20788003 | 0.91 | KMT2A (0.50) | CES2KMT2AMEN1FAAHMAPK1 | |
| Dimethylamine SCHEMBL20788004 | 0.91 | KMT2A (0.50) | CES2KMT2AMEN1FAAHMAPK1 | |
| Trimethylammonium SCHEMBL29000430 | 0.91 | CES2 (0.48) | CES2KMT2AMEN1FAAHMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3456714-B1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE AND KIT | TOSHIBA KK (JP) | 2023-11-15 | — | — | EP | claimed |
| US-10639279-B2 | Biodegradable compound, lipid particle, composition containing lipid particle, and kit | KABUSHIKI KAISHA TOSHIBA (JP) | 2020-05-05 | — | — | US | claimed |
| EP-3456714-A1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE AND KIT | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-03-20 | — | — | EP | claimed |
| US-20190076358-A1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE, AND KIT | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-03-14 | — | — | US | claimed |
| EP-3456714-B1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE AND KIT | TOSHIBA KK (JP) | 2023-11-15 | — | — | EP | disclosed |
| US-10639279-B2 | Biodegradable compound, lipid particle, composition containing lipid particle, and kit | KABUSHIKI KAISHA TOSHIBA (JP) | 2020-05-05 | — | — | US | disclosed |
| EP-3456714-A1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE AND KIT | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-03-20 | — | — | EP | disclosed |
| US-20190076358-A1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE, AND KIT | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190076358-A1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE, AND KIT | ACSL4, KIT, LIPC | CES2 573/4885KMT2A 904/4885MEN1 2379/4885 |
| US-10639279-B2 | Biodegradable compound, lipid particle, composition containing lipid particle, and kit | ACSL4, KIT, CCKAR | CES2 644/4885KMT2A 1011/4885MEN1 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.